FIELD: organic chemistry, steroids, pharmacy. SUBSTANCE: invention represents novel androgen (β)-7-methyl-[(1-oxoundecyl)oxy]-estr-4-ene-3-one (undecanoate MEHT). This compound in contrast from other derivatives of testosterone shows good solubility in oily media. In part, it shows good effectiveness in solution as compared with testosterone. Compound is suitable especially for administration by injection route. EFFECT: improved and valuable medicinal properties of compound. 6 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STEROID COMPOUND, ITS USING AND TREATMENT METHOD | 2002 |
|
RU2294332C2 |
| COMPOSITION COMPRISING TESTOSTERONE UNDECANOATE AND CASTOR OIL | 2000 |
|
RU2246296C2 |
| COMPOUNDS, SET, ANDROGENIC COMPOSITION | 2000 |
|
RU2242479C2 |
| CONTRACEPTIVE INJECTION OF OIL SOLUTION INJECTED INDEPENDENTLY | 2003 |
|
RU2328289C2 |
| USE OF NOVEL ETHONOGESTREL ESTERS | 2003 |
|
RU2322986C2 |
| STEROIDS WITH MIXED ANDROGENIC AND PROGESTAGENIC PROFILE | 2004 |
|
RU2357972C2 |
| 3-METHYLENE-STEROID DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 2000 |
|
RU2248358C2 |
| DERIVATIVE OF 11-(PHENYL-SUBSTITUTED)-ESTRA-4,9-DIENE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2135514C1 |
| DERIVATIVES OF 16-HYDROXY-11-(SUBSTITUTED PHENYL)-ESTRA-4,9-DIENE, COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2187510C2 |
| STEROID COMPOUNDS, METHOD FOR SELECTIVE MODIFICATION, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2255090C2 |
